Skip to main content
. 2022 Feb 16;13:824362. doi: 10.3389/fendo.2022.824362

Figure 4.

Figure 4

(A) The nomogram for predicting the 1-, 2-, and 3- year relapse-free survival in breast cancer patients, based on the autophagy-related 4-gene signature selection and clinical factors. (B) The 1-, 2- and 3-year calibration curves were derived from the nomogram, respectively.